http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3220326-C2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4826 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
| filingDate | 1982-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1985-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1985-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-3220326-C2 |
| titleOfInvention | Carcinoma therapeutic |
| abstract | A combination of glycosaminoglycan polysulfate with a cytostatic has good results in the selective killing of tumor cells. This effect can be intensified by lipolytic and / or proteolytic enzyme. |
| priorityDate | 1982-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 59.